A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors

Clinical trial NCT04841538 · WITHDRAWN

Trial details

NCT number: NCT04841538
Sponsor: Elpiscience Biopharma, Ltd.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thoracic Tumors Non-small Cell Lung Cancer Small Cell Lung Cancer

Start date: 2021-07-01
Primary completion: 2023-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.